Breakthrough AI-Powered Reimbursement Codes for Cardio Diagnostics
Breakthrough AI-Powered Reimbursement Codes for Cardio Diagnostics (NASDAQ: CDIO)
The Wave of Innovation Cardio Diagnostics’ revolutionary AI-driven coronary heart disease (CHD) tests have achieved a major milestone by securing two dedicated Current Procedural Terminology (CPT) Proprietary Laboratory Analysis (PLA) codes: 0440U for the AI-driven CHD detection test, PrecisionCHD, and 0439U for the AI-driven CHD event risk assessment test, Epi+Gen CHD. Approved by the American ...












